We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$270M
AUM Growth
+$52.1M
Cap. Flow
+$22M
Cap. Flow %
8.14%
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.34M
2
XOM icon
ExxonMobil
XOM
+$1.31M
3
CVX icon
Chevron
CVX
+$1.25M
4
LLY icon
Eli Lilly
LLY
+$685K
5
JPM icon
JPMorgan Chase
JPM
+$684K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.18M
2
NVDA icon
NVIDIA
NVDA
+$618K
3
AVGO icon
Broadcom
AVGO
+$138K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$113K
5
AAPL icon
Apple
AAPL
+$105K

Sector Composition

Rank Sector Weight
1 Technology 44.15%
2 Healthcare 9.98%
3 Consumer Staples 7.57%
4 Financials 6.32%
5 Industrials 6.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AN icon
601
AutoNation
AN
$6.97B
$8.28K ﹤0.01%
+50
New +$7.36K
APD icon
602
Air Products & Chemicals
APD
$66.3B
$8.24K ﹤0.01%
34
– –
IFLN
603
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$305M
$8.16K ﹤0.01%
450
– –
CRBN icon
604
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.12B
$8.08K ﹤0.01%
45
– –
OVV icon
605
Ovintiv
OVV
$17.5B
$7.99K ﹤0.01%
+154
New +$7.01K
ROCK icon
606
Gibraltar Industries
ROCK
$1.34B
$7.97K ﹤0.01%
+99
New +$7.89K
CRSP icon
607
CRISPR Therapeutics
CRSP
$4.58B
$7.91K ﹤0.01%
116
– –
IDHQ icon
608
Invesco S&P International Developed Quality ETF
IDHQ
$908M
$7.76K ﹤0.01%
253
– –
GMED icon
609
Globus Medical
GMED
$10.4B
$7.72K ﹤0.01%
+144
New +$7.74K
BLDR icon
610
Builders FirstSource
BLDR
$7.84B
$7.72K ﹤0.01%
+37
New +$6.84K
APG icon
611
APi Group
APG
$17.1B
$7.66K ﹤0.01%
+293
New +$6.82K
SUI icon
612
Sun Communities
SUI
$15B
$7.64K ﹤0.01%
+59
New +$7.66K
ANSS
613
DELISTED
Ansys
ANSS
$7.64K ﹤0.01%
+22
New +$7.45K
MDU icon
614
MDU Resources
MDU
$4.44B
$7.6K ﹤0.01%
542
– –
ZBRA icon
615
Zebra Technologies
ZBRA
$12.4B
$7.54K ﹤0.01%
+25
New +$6.69K
AZTA icon
616
Azenta
AZTA
$1.26B
$7.54K ﹤0.01%
+125
New +$8.01K
HUBS icon
617
HubSpot
HUBS
$10.5B
$7.52K ﹤0.01%
+12
New +$7.21K
PSK icon
618
State Street SPDR ICE Preferred Securities ETF
PSK
$693M
$7.5K ﹤0.01%
215
– –
EGP icon
619
EastGroup Properties
EGP
$11.5B
$7.42K ﹤0.01%
+41
New +$7.39K
CMCO icon
620
Columbus McKinnon
CMCO
$465M
$7.41K ﹤0.01%
+166
New +$6.71K
NXST icon
621
Nexstar Media Group
NXST
$5.6B
$7.41K ﹤0.01%
+43
New +$7.22K
ACHC icon
622
Acadia Healthcare
ACHC
$3.17B
$7.37K ﹤0.01%
+93
New +$7.61K
SCHR
623
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
$7.36K ﹤0.01%
300
– –
SLAB icon
624
Silicon Laboratories
SLAB
$7.15B
$7.33K ﹤0.01%
+51
New +$6.76K
KDP icon
625
Keurig Dr Pepper
KDP
$40.4B
$7.29K ﹤0.01%
+236
New +$7.27K
23 24
25
26 27

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.

By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.

  • Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
  • Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
  • Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
  • Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
  • Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
  • Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
  • Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.

Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.